Founded Date: 2019-01-01
Last Funding Type: Series A
Headquarters: Paris, Ile-de-France, France
Investors Number: 5.0
Industry: Early Drug Development
Last Funding Date: 2022-09-02
Funding Status: Early Stage Venture
Total Funding: 6000000.0